Implantica adds another RefluxStop™ center in Spain
), a medtech company at the forefront of bringing advanced technology into the body, announces another key public hospital in Spain successfully completed its first RefluxStop™ procedures.
- ), a medtech company at the forefront of bringing advanced technology into the body, announces another key public hospital in Spain successfully completed its first RefluxStop™ procedures.
- Dr. Pablo Priego performed his first two RefluxStop™ procedures at Universitario Ramón y Cajal Hospital in Madrid, Spain.
- The RefluxStop™ procedure aims to address the root cause of acid reflux or GERD without affecting the food passageway, allowing the body to function normally.
- Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.